NO885833L - Antibiotikum reuterin. - Google Patents

Antibiotikum reuterin.

Info

Publication number
NO885833L
NO885833L NO88885833A NO885833A NO885833L NO 885833 L NO885833 L NO 885833L NO 88885833 A NO88885833 A NO 88885833A NO 885833 A NO885833 A NO 885833A NO 885833 L NO885833 L NO 885833L
Authority
NO
Norway
Prior art keywords
reuterin
antibiotic
effective
prodn
glycerol
Prior art date
Application number
NO88885833A
Other languages
English (en)
Other versions
NO301430B1 (no
NO885833D0 (no
Inventor
Walter J Dobrogosz
Sven E Lindgren
Original Assignee
Probiologics International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiologics International Inc filed Critical Probiologics International Inc
Publication of NO885833D0 publication Critical patent/NO885833D0/no
Publication of NO885833L publication Critical patent/NO885833L/no
Priority to NO963930A priority Critical patent/NO308982B1/no
Publication of NO301430B1 publication Critical patent/NO301430B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO885833A 1987-05-01 1988-12-30 Fremgangsmåte for fremstilling av reuterin, anvendelse av en karbonkilde for screening av isolater av Lactobacillus reuteri, anvendelser av reuterin, samt biologisk ren stamme av L. reuteri NO301430B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO963930A NO308982B1 (no) 1987-05-01 1996-09-19 Anvendelse av Lactobacillus reuteri for ikke-terapeutiske formÕl

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4602787A 1987-05-01 1987-05-01
US10283087A 1987-09-22 1987-09-22
PCT/US1988/001423 WO1988008452A1 (en) 1987-05-01 1988-04-28 Antibiotic reuterin

Publications (3)

Publication Number Publication Date
NO885833D0 NO885833D0 (no) 1988-12-30
NO885833L true NO885833L (no) 1989-02-28
NO301430B1 NO301430B1 (no) 1997-10-27

Family

ID=26723487

Family Applications (2)

Application Number Title Priority Date Filing Date
NO885833A NO301430B1 (no) 1987-05-01 1988-12-30 Fremgangsmåte for fremstilling av reuterin, anvendelse av en karbonkilde for screening av isolater av Lactobacillus reuteri, anvendelser av reuterin, samt biologisk ren stamme av L. reuteri
NO963930A NO308982B1 (no) 1987-05-01 1996-09-19 Anvendelse av Lactobacillus reuteri for ikke-terapeutiske formÕl

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO963930A NO308982B1 (no) 1987-05-01 1996-09-19 Anvendelse av Lactobacillus reuteri for ikke-terapeutiske formÕl

Country Status (10)

Country Link
EP (2) EP0698347B1 (no)
JP (2) JP3007092B2 (no)
AT (2) ATE145243T1 (no)
AU (1) AU620807B2 (no)
CA (1) CA1314255C (no)
DE (2) DE3856591D1 (no)
DK (1) DK174229B1 (no)
FI (2) FI895197A0 (no)
NO (2) NO301430B1 (no)
WO (1) WO1988008452A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198425A (en) * 1989-08-30 1993-03-30 Bio-Mega, Inc. Inhibitors of bacterial ribonucleotide reductase
ES2174829T3 (es) * 1991-01-28 2002-11-16 Biogaia Ab Metodo para administrar el microorganismo lactobacillus reuteri como alimentacion directa a un organismo avicola in ovo.
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
GB9803424D0 (en) * 1998-02-18 1998-04-15 Pfizer Ltd Performance enhancement
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
JP5799299B2 (ja) 2007-02-01 2015-10-21 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8617537B2 (en) * 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
EP2158813A1 (en) 2008-08-28 2010-03-03 Omya Development AG Stabilisation of aqueous mineral preparations by reuterin
WO2010045367A1 (en) * 2008-10-14 2010-04-22 Dr Pepper/Seven Up, Inc. Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
ES2611028T3 (es) * 2011-11-30 2017-05-04 Compagnie Gervais Danone Lactobacillus brevis productor de reuterina
CA2868288A1 (en) 2012-04-16 2013-10-24 Cascades Canada Ulc Antimicrobial compositions comprising pediocin, lactic acid and citric acid and uses thereof
JP2015520773A (ja) * 2012-05-29 2015-07-23 ダヌタ・クルセフスカＤａｎｕｔａＫＲＵＳＺＥＷＳＫＡ ヒトおよび動物における予防および医薬に有用であるラクトバチルス・ロイテリｄａｎ８０を含むナノ製品ならびにこれらの医薬用途
EP2674162A1 (en) * 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
CA2923982A1 (en) 2013-08-12 2015-02-19 Mansel Griffiths Antiviral methods and compositions comprising probiotic bacterial molecules
ITUB20152987A1 (it) * 2015-08-07 2017-02-07 Minaba Tech S R L Procedimento di bio-conservazione di prodotti ittici e relativi prodotti
CN105340974B (zh) * 2015-10-30 2018-01-09 湖北省生物农药工程研究中心 一种生物拌种剂及应用
CN114806929B (zh) * 2022-03-29 2023-10-31 山东凤凰生物科技股份有限公司 一株高产罗伊氏菌素的罗伊氏乳杆菌lr4009及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687981A (en) * 1968-01-17 1972-08-29 Du Pont Process for making a dioxane
US4053638A (en) * 1970-05-06 1977-10-11 William Wrigley Jr. Company Anticaries confectioneries and oral health products
JPS60116369U (ja) 1984-01-11 1985-08-06 リョービ株式会社 ゴルフクラブメタルヘツド
US10283087B2 (en) 2016-06-15 2019-05-07 Sk Planet Co., Ltd. Digital signage device and method for operating the same

Also Published As

Publication number Publication date
NO963930D0 (no) 1996-09-19
DE3855664T2 (de) 1997-03-20
DK542889D0 (da) 1989-10-31
EP0357673A1 (en) 1990-03-14
ATE332649T1 (de) 2006-08-15
JP3007092B2 (ja) 2000-02-07
FI960543A0 (fi) 1996-02-06
JPH11137292A (ja) 1999-05-25
JP3244659B2 (ja) 2002-01-07
FI895197A0 (fi) 1989-11-01
AU620807B2 (en) 1992-02-27
NO301430B1 (no) 1997-10-27
NO308982B1 (no) 2000-11-27
EP0698347A3 (en) 1999-09-08
FI960543A (fi) 1996-02-06
EP0698347B1 (en) 2006-07-12
CA1314255C (en) 1993-03-09
EP0357673A4 (en) 1991-09-25
JPH02503385A (ja) 1990-10-18
NO885833D0 (no) 1988-12-30
DK542889A (da) 1989-10-31
DE3856591D1 (de) 2006-08-24
FI110366B (fi) 2002-12-31
AU1724588A (en) 1988-12-02
ATE145243T1 (de) 1996-11-15
WO1988008452A1 (en) 1988-11-03
NO963930L (no) 1989-02-28
DE3855664D1 (de) 1996-12-19
EP0698347A2 (en) 1996-02-28
DK174229B1 (da) 2002-10-07
EP0357673B1 (en) 1996-11-13

Similar Documents

Publication Publication Date Title
ATE145243T1 (de) Antibiotikum-reuterin
McDonald et al. Enhanced recovery of injured Escherichia coli by compounds that degrade hydrogen peroxide or block its formation
Krumholz et al. Eubacterium oxidoreducens sp. nov. requiring H 2 or formate to degrade gallate, pyrogallol, phloroglucinol and quercetin
JP2002017342A5 (no)
ES8204762A1 (es) Un metodo para preparar acido 2,5-diceto-d-gluconico
PT721989E (pt) Oligonucleotido para a deteccao de salmonella
Friedman Inhibition of staphylococcal enterotoxin B formation in broth cultures
Daron Occurrence of isocitrate lyase in a thermophilic Bacillus species
ES2051890T3 (es) Procedimiento para aislar la enzima carnitinhidroliasa de cepas pertenecientes a la familia enterobacteriaceae y empleo de la enzima inmobilizada para producir l(-)-carnitina.
Phillips et al. A novel inhibitor of NADH dehydrogenase in Paracoccus denitrificans.
SE7612293L (sv) Antibiotikum
JPS5942893A (ja) 微生物によるジメチルリン酸の酸化分解法
FI905055A0 (fi) Ett p1-bakteriofagkloningssystem foer sao stora dna-fragment som 95 kb.
Nisman et al. Diphosphopyridine nucleotide and phosphate requirement for oxidation of amino-acids by cell-free extracts of obligate anaerobes
JPS559707A (en) Production of cells of microorganism
JPS5736981A (en) Solution composition of liquefied spirulina and its preparation
Weinstein ISOLATION, CHARACTERIZATION, AND STUDIES OF THE MECHANISM OF ACTION OF GLYCINOL, A SOYBEAN PHYTOALEXIN.
JPS5743697A (en) Improved preparation of antibiotic
Smit Specific Activity of Phenylalanine Deaminase in Extracts of the Proteus–Providence Group
Calabrese Enhanced detection of injured coliform bacteria by modification of standard recovery media.
Farah Control of foodborne pathogens in low water activity systems by diacetyl.
JPS5523966A (en) Production of cephalosporin compound
JPS55114297A (en) Production of beta-lactam type antibiotic
Andreasen et al. INFLUENCE OF CARBON‐DIOXIDE TENSION AND MEDIUM BUFFER CONCENTRATION ON MEDIUM pH AND MIC VALUES OF ERYTHROMYCIN FOR ESCHERICHIA COLI ATCC 25922 AND STAPHYLOCOCCUS AUREUS ATCC 25923 IN A MICRO‐AEROBIC ATMOSPHERE
KR940002360A (ko) 미생물을 이용한 5-히드록시피라진카본산 및 그의 염의 제조방법

Legal Events

Date Code Title Description
MK1K Patent expired